GENESIS Ventures

GENESIS Ventures is an investment vehicle based in Barcelona, established in partnership with family offices. With a fund size of €610,000, the company focuses on investing in early-stage start-ups and entrepreneurial projects within the biomedical and biotechnological sectors. Their goal is to support the development of innovative products by funding the creation of start-up companies in areas such as therapeutics, diagnostics, and medical devices. GENESIS Ventures acts as an early-stage platform to assist promising scientific projects in reaching key value milestones, thereby attracting further investment from venture or corporate funds.

Past deals in Catalonia

ABLE Human Motion

Seed Round in 2019
ABLE Human Motion is a Barcelona-based medical device company founded in 2018. It specializes in developing robotic exoskeletons, with its flagship product being the ABLE Exoskeleton. This wearable technology actively assists paraplegic individuals to stand up, walk, and sit down, aiming to enhance rehabilitation efficiency for clinicians and empower users with greater mobility and independence.

Mowoot

Equity Crowdfunding in 2019
Mowoot is a company that specializes in developing wearable medical devices aimed at improving the quality of life for individuals suffering from chronic constipation. Founded in 2014 and based in Barcelona, Spain, Mowoot offers a non-pharmacological and non-invasive solution that simulates a manual abdominal massage performed by healthcare professionals. Utilizing advanced pneumatic technology, its device provides automatic colon-specific massages to stimulate intestinal transit, thereby helping to treat and prevent chronic slow transit constipation without the need for colon cleansing supplements, enemas, or laxatives. Mowoot emerged from the MOEBIO dHEALTH program, drawing inspiration from concepts in design and business innovation.

NeuroHeal

Seed Round in 2018
NeuroHeal is a spinout from the Institut of Neurosciences from the Autonomous University of Barcelona.

ADmit Therapeutics

Seed Round in 2018
ADmit Therapeutics is a biotechnology company that develops diagnostic tests for early detection of Alzheimer’s disease. Its blood-based assay uses epigenetic analysis to assess mitochondrial DNA methylation, including methylcytosines, through next-generation sequencing, and does not rely on beta-amyloid or tau markers. The test is intended to aid pharmaceutical research by enabling early diagnosis and streamlined drug development. The company was founded in 2017 and is based in Begues, Spain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.